GlassScriptPhysician profile
John J Caponigro
NPI 1659338564
$19,651.44
in general payments reported to CMS, 2019-2025
15 companies · $5,120 in 2025
The $5,120 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.20 · 2020: $55.43 · 2021: $7,528 · 2022: $4,325 · 2023: $400 · 2024: $2,127 · 2025: $5,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,851 · Consulting Fee: $2,000 · Food and Beverage: $1,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,851.00 |
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,796.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $17,829.59 | 2021-2025 | Lapidus, Io Fix |
| Stryker Corporation | $947.68 | 2019-2025 | Citrefix, Infinity Adaptis, Ortholoc 3di |
| Kerecis Limited | $283.01 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Globus Medical, INC. | $169.66 | 2025 | Senza |
| Smith+Nephew, INC. | $127.29 | 2021 | |
| Cardiovascular Systems INC. | $47.68 | 2019 | |
| Orthofix Medical, INC. | $39.73 | 2022 | |
| Integra Lifesciences Corporation | $36.16 | 2019-2020 | |
| Paragon 28, INC. | $34.02 | 2024 | Gorilla, Precision Mis Bunion |
| Treace Medical Concepts, INC. | $32.37 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $28.15 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $27.53 | 2025 | |
| Orpyx Medical Technologies US INC. | $19.65 | 2023 | Orpyx Si |
| Acadia Pharmaceuticals INC | $16.09 | 2025 | Nuplazid |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Caponigro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.